1. Home
  2. SNY vs GEOS Comparison

SNY vs GEOS Comparison

Compare SNY & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • GEOS
  • Stock Information
  • Founded
  • SNY 1994
  • GEOS 1980
  • Country
  • SNY France
  • GEOS United States
  • Employees
  • SNY N/A
  • GEOS N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • GEOS Industrial Machinery/Components
  • Sector
  • SNY Health Care
  • GEOS Industrials
  • Exchange
  • SNY Nasdaq
  • GEOS Nasdaq
  • Market Cap
  • SNY 113.4B
  • GEOS 72.9M
  • IPO Year
  • SNY N/A
  • GEOS 1997
  • Fundamental
  • Price
  • SNY $46.61
  • GEOS $17.21
  • Analyst Decision
  • SNY Buy
  • GEOS
  • Analyst Count
  • SNY 4
  • GEOS 0
  • Target Price
  • SNY $61.50
  • GEOS N/A
  • AVG Volume (30 Days)
  • SNY 2.8M
  • GEOS 191.3K
  • Earning Date
  • SNY 10-24-2025
  • GEOS 08-07-2025
  • Dividend Yield
  • SNY 3.43%
  • GEOS N/A
  • EPS Growth
  • SNY 118.56
  • GEOS N/A
  • EPS
  • SNY 8.65
  • GEOS N/A
  • Revenue
  • SNY $53,714,621,258.00
  • GEOS $115,527,000.00
  • Revenue This Year
  • SNY $1.53
  • GEOS N/A
  • Revenue Next Year
  • SNY $7.06
  • GEOS N/A
  • P/E Ratio
  • SNY $5.39
  • GEOS N/A
  • Revenue Growth
  • SNY 15.65
  • GEOS N/A
  • 52 Week Low
  • SNY $44.73
  • GEOS $5.51
  • 52 Week High
  • SNY $60.12
  • GEOS $21.60
  • Technical
  • Relative Strength Index (RSI)
  • SNY 40.69
  • GEOS 51.03
  • Support Level
  • SNY $46.79
  • GEOS $16.10
  • Resistance Level
  • SNY $47.69
  • GEOS $17.29
  • Average True Range (ATR)
  • SNY 0.68
  • GEOS 1.34
  • MACD
  • SNY -0.26
  • GEOS -0.41
  • Stochastic Oscillator
  • SNY 27.40
  • GEOS 29.45

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

Share on Social Networks: